226 related articles for article (PubMed ID: 30374604)
1. Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease.
Moreira JM; da Silva AN; Marciano Vieira ÉL; Teixeira AL; Kummer AM; Simões E Silva AC
Pediatr Nephrol; 2019 Feb; 34(2):349-352. PubMed ID: 30374604
[TBL] [Abstract][Full Text] [Related]
2. Circulating cathepsin-S levels correlate with GFR decline and sTNFR1 and sTNFR2 levels in mice and humans.
Steubl D; Kumar SV; Tato M; Mulay SR; Larsson A; Lind L; Risérus U; Renders L; Heemann U; Carlsson AC; Ärnlöv J; Anders HJ
Sci Rep; 2017 Feb; 7():43538. PubMed ID: 28240259
[TBL] [Abstract][Full Text] [Related]
3. Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes.
Gómez-Banoy N; Cuevas V; Higuita A; Aranzález LH; Mockus I
J Diabetes Complications; 2016 Jul; 30(5):852-7. PubMed ID: 27068267
[TBL] [Abstract][Full Text] [Related]
4. Potential Role of Soluble TNF-α Receptors in Diagnosis of Patients with Chronic Kidney Disease.
Xun C; Zhao Y
Ann Clin Lab Sci; 2017 May; 47(3):310-314. PubMed ID: 28667032
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.
Safranow K; Dziedziejko V; Rzeuski R; Czyzycka E; Wojtarowicz A; Bińczak-Kuleta A; Jakubowska K; Olszewska M; Ciechanowicz A; Kornacewicz-Jach Z; Machaliński B; Pawlik A; Chlubek D
Tissue Antigens; 2009 Nov; 74(5):386-92. PubMed ID: 19845893
[TBL] [Abstract][Full Text] [Related]
6. TNF-α and soluble forms of TNF receptors 1 and 2 in the serum of patients with Crohn's disease and ulcerative colitis.
Owczarek D; Cibor D; Głowacki MK; Cieśla A; Mach P
Pol Arch Med Wewn; 2012; 122(12):616-23. PubMed ID: 23160117
[TBL] [Abstract][Full Text] [Related]
7. Association between serum soluble TNFα receptors and renal dysfunction in type 2 diabetic patients without proteinuria.
Miyazawa I; Araki S; Obata T; Yoshizaki T; Morino K; Kadota A; Ugi S; Kawai H; Uzu T; Nishio Y; Koya D; Haneda M; Kashiwagi A; Maegawa H
Diabetes Res Clin Pract; 2011 May; 92(2):174-80. PubMed ID: 21288590
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin reduced soluble receptors of TNF-alpha in systemic lupus erythematosus.
Ferreira GA; Teixeira AL; Calderaro DC; Sato EI
Clin Exp Rheumatol; 2016; 34(1):42-8. PubMed ID: 26574625
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha (TNF-α) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis.
Ribeiro CM; Oliveira SR; Alfieri DF; Flauzino T; Kaimen-Maciel DR; Simão ANC; Maes M; Reiche EMV
Inflamm Res; 2019 Dec; 68(12):1049-1059. PubMed ID: 31559449
[TBL] [Abstract][Full Text] [Related]
10. Soluble TNF receptors are produced at sites of inflammation and are inversely associated with self-reported symptoms (WOMAC) in knee osteoarthritis.
Simão AP; Almeida TM; Mendonça VA; Santos SA; Gomes WF; Coimbra CC; Lacerda AC
Rheumatol Int; 2014 Dec; 34(12):1759-63. PubMed ID: 24748490
[TBL] [Abstract][Full Text] [Related]
11. Structural damage in diabetic nephropathy is associated with TNF-α system activity.
Fernández-Real JM; Vendrell J; García I; Ricart W; Vallès M
Acta Diabetol; 2012 Aug; 49(4):301-5. PubMed ID: 22042131
[TBL] [Abstract][Full Text] [Related]
12. Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study.
Neirynck N; Glorieux G; Schepers E; Verbeke F; Vanholder R
PLoS One; 2015; 10(3):e0122073. PubMed ID: 25823004
[TBL] [Abstract][Full Text] [Related]
13. Relationships of Measured Iohexol GFR and Estimated GFR With CKD-Related Biomarkers in Children and Adolescents.
Ng DK; Schwartz GJ; Warady BA; Furth SL; Muñoz A
Am J Kidney Dis; 2017 Sep; 70(3):397-405. PubMed ID: 28549535
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis.
Parodis I; Ding H; Zickert A; Arnaud L; Larsson A; Svenungsson E; Mohan C; Gunnarsson I
Scand J Rheumatol; 2017 Jul; 46(4):263-272. PubMed ID: 27973968
[TBL] [Abstract][Full Text] [Related]
15. Parallel assessment of albuminuria and plasma sTNFR1 in people with type 2 diabetes and advanced chronic kidney disease provides accurate prognostication of the risks of renal decline and death.
Martin WP; Tuohy C; Doody A; Jackson S; Canavan RJ; Slattery D; Twomey PJ; McKenna MJ; le Roux CW; Docherty NG
Sci Rep; 2020 Sep; 10(1):14852. PubMed ID: 32908199
[TBL] [Abstract][Full Text] [Related]
16. Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis.
Patel M; Oni L; Midgley A; Smith E; Tullus K; Marks SD; Jones CA; Pilkington C; Beresford MW
Lupus; 2016 Aug; 25(9):1040-4. PubMed ID: 26854079
[TBL] [Abstract][Full Text] [Related]
17. Plasma Biomarkers of Tubular Injury and Inflammation Are Associated with CKD Progression in Children.
Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Gonzalez MC; Coca S; Schrauben SJ; Waikar SS; Ramachandran VS; Shlipak MG; Warady B; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S;
J Am Soc Nephrol; 2020 May; 31(5):1067-1077. PubMed ID: 32234829
[TBL] [Abstract][Full Text] [Related]
18. Association of Soluble TNFR-1 Concentrations with Long-Term Decline in Kidney Function: The Multi-Ethnic Study of Atherosclerosis.
Bhatraju PK; Zelnick LR; Shlipak M; Katz R; Kestenbaum B
J Am Soc Nephrol; 2018 Nov; 29(11):2713-2721. PubMed ID: 30287518
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.
Niewczas MA; Ficociello LH; Johnson AC; Walker W; Rosolowsky ET; Roshan B; Warram JH; Krolewski AS
Clin J Am Soc Nephrol; 2009 Jan; 4(1):62-70. PubMed ID: 19073786
[TBL] [Abstract][Full Text] [Related]
20. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
Doganavsargil-Baysal O; Cinemre B; Aksoy UM; Akbas H; Metin O; Fettahoglu C; Gokmen Z; Davran F
Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
